EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | February 8th, 2025

Here are the top stories from the last week:

FDA Approves New Indication for Novo Nordisk’s Ozempic
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease. Read more »

CVS Pharmacy, Duquesne University Intro Program to Address Pharmacist Shortage
The collaboration is intended to remove financial barriers to higher education and support the talent pipeline for future pharmacists. Read more »

American Pharmacists Association Announces Rollout of HealthShifts
APhA, in collaboration with CPhA and Locumate, has announced the rollout of HealthShifts, a new initiative aimed at enhancing pharmacy services. Read more »

Caring for the Caregiver: Prioritizing Well-Being as a Pharmacist
This article discusses the challenges faced by pharmacists, including long hours, high stress, and emotional strain, and emphasizes the importance of prioritizing self-care. Read more »

NACDS Promotes Pharmacies’ Role in Heart Health
NACDS launched the Nourish My Health campaign to promote heart health services offered by member pharmacies at over 25,000 locations nationwide. Read more »

FTC Adds Fuel to the Fire for PBMs. Will Congress Deliver Real Reform?
The op-ed discusses the need for reform in pharmacy benefit managers (PBMs) and suggests that Congress may need to reconsider its approach to effectively serve the American public. Read more »

Texas Attorney General Rules Wisely on State PBM Reform’s Enforceability
NACDS praised Texas Attorney General Paxton’s ruling on the enforceability of state PBM reforms, stating that it will help Texans and more Americans by reducing flimsy PBM excuses. Read more »

IQVIA Researches the Cost of the 340B Program to States
New research from IQVIA indicates that the 340B program increases costs for employers and state and local governments, with potential further increases due to contract pharmacy legislation. Read more »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®